NCT01258231 Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
| NCT ID | NCT01258231 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brigham and Women's Hospital |
| Condition | Heart; Dysfunction Postoperative, Cardiac Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2000-08 |
| Primary Completion | 2030-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2000-08 with a primary completion date of 2030-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Eligibility Criteria
Inclusion Criteria: * Undergoing heart surgery * Willing to provide consent Exclusion Criteria: * Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Contact & Investigator
Jochen D Muehlschlegel, MD MMSc, MPH
PRINCIPAL INVESTIGATOR
Brigham and Women's Hospital
Frequently Asked Questions
Who can join the NCT01258231 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Heart; Dysfunction Postoperative, Cardiac Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01258231 currently recruiting?
Yes, NCT01258231 is actively recruiting participants. Visit ClinicalTrials.gov or contact Brigham and Women's Hospital to inquire about joining.
Where is the NCT01258231 trial being conducted?
This trial is being conducted at Boston, United States, Dallas, United States, Houston, United States.
Who is sponsoring the NCT01258231 clinical trial?
NCT01258231 is sponsored by Brigham and Women's Hospital. The principal investigator is Jochen D Muehlschlegel, MD MMSc, MPH at Brigham and Women's Hospital. The trial plans to enroll 4,000 participants.